REGN

Regeneron Pharmaceuticals

NASDAQ · Biotechnology

$785.51

+18.88 (+2.46%)

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Buy

30 analysts

Buy 19 63%

Hold 7 23%

Sell 4 13%

Price Target

Analyst Price Target -90.2% upside

Low Target $61.79

Average Target $76.80

High Target $111.17

Current Price $785.51

Current
$785.51

Target
$76.80

$61.79 $76.80 avg $111.17